Mapping of the benzodiazepine recognition site on GABA(A) receptors
- PMID:12171574
- DOI: 10.2174/1568026023393444
Mapping of the benzodiazepine recognition site on GABA(A) receptors
Abstract
Ligands of the benzodiazepine binding site of the GABAA receptor come in three flavors: positive allosteric modulators, negative allosteric modulators and antagonists, all of which can bind with high affinity. The GABA(A) receptor is a pentameric protein which forms a chloride selective ion channel and ligands of the benzodiazepine binding site stabilize three different conformations of this receptor channel. Classical benzodiazepines exert a positive allosteric effect by increasing the affinity of channel opening by the agonist gamma-aminobutyric acid (GABA). We concentrate here on the major adult isoform, the alpha1beta2gamma2 GABA(A) receptor. The binding pocket for benzodiazepines is located in a subunit cleft between gamma2 and alpha1 subunits in a position homologous to the agonist binding site for GABA that is located between alpha1 and beta2 subunits. It is reviewed here how we arrived at this picture. In particular, point mutations were performed in combination with subsequent analysis of the expressed mutant proteins using either electrophysiological techniques or radioactive ligand binding assays. The predictive power of these methods is assessed by comparing the results with the predictions that can be made on the basis of the recently published crystal structure of the acetylcholine binding protein that shows homology to the N-terminal, extracellular domain of the GABA(A) receptor.
Similar articles
- A closer look at the high affinity benzodiazepine binding site on GABAA receptors.Sigel E, Lüscher BP.Sigel E, et al.Curr Top Med Chem. 2011;11(2):241-6. doi: 10.2174/156802611794863562.Curr Top Med Chem. 2011.PMID:21189125Review.
- Mutagenesis of the GABA(A) receptor alpha1 subunit reveals a domain that affects sensitivity to GABA and benzodiazepine-site ligands.Davies M, Newell JG, Dunn SM.Davies M, et al.J Neurochem. 2001 Oct;79(1):55-62. doi: 10.1046/j.1471-4159.2001.00527.x.J Neurochem. 2001.PMID:11595757
- A point mutation in the gamma2 subunit of gamma-aminobutyric acid type A receptors results in altered benzodiazepine binding site specificity.Buhr A, Sigel E.Buhr A, et al.Proc Natl Acad Sci U S A. 1997 Aug 5;94(16):8824-9. doi: 10.1073/pnas.94.16.8824.Proc Natl Acad Sci U S A. 1997.PMID:9238062Free PMC article.
- Positive modulation of synaptic and extrasynaptic GABAA receptors by an antagonist of the high affinity benzodiazepine binding site.Middendorp SJ, Maldifassi MC, Baur R, Sigel E.Middendorp SJ, et al.Neuropharmacology. 2015 Aug;95:459-67. doi: 10.1016/j.neuropharm.2015.04.027. Epub 2015 May 9.Neuropharmacology. 2015.PMID:25963418
- The Benzodiazepine Binding Sites of GABAA Receptors.Sigel E, Ernst M.Sigel E, et al.Trends Pharmacol Sci. 2018 Jul;39(7):659-671. doi: 10.1016/j.tips.2018.03.006. Epub 2018 Apr 30.Trends Pharmacol Sci. 2018.PMID:29716746Review.
Cited by
- Preclinical characterization of zuranolone (SAGE-217), a selective neuroactive steroid GABAA receptor positive allosteric modulator.Althaus AL, Ackley MA, Belfort GM, Gee SM, Dai J, Nguyen DP, Kazdoba TM, Modgil A, Davies PA, Moss SJ, Salituro FG, Hoffmann E, Hammond RS, Robichaud AJ, Quirk MC, Doherty JJ.Althaus AL, et al.Neuropharmacology. 2020 Dec 15;181:108333. doi: 10.1016/j.neuropharm.2020.108333. Epub 2020 Sep 22.Neuropharmacology. 2020.PMID:32976892Free PMC article.
- Benzodiazepine-site pharmacology on GABAA receptors in histaminergic neurons.May AC, Fleischer W, Kletke O, Haas HL, Sergeeva OA.May AC, et al.Br J Pharmacol. 2013 Sep;170(1):222-32. doi: 10.1111/bph.12280.Br J Pharmacol. 2013.PMID:23799902Free PMC article.
- General Anesthetic Binding Sites in Human α4β3δ γ-Aminobutyric Acid Type A Receptors (GABAARs).Chiara DC, Jounaidi Y, Zhou X, Savechenkov PY, Bruzik KS, Miller KW, Cohen JB.Chiara DC, et al.J Biol Chem. 2016 Dec 16;291(51):26529-26539. doi: 10.1074/jbc.M116.753335. Epub 2016 Nov 7.J Biol Chem. 2016.PMID:27821594Free PMC article.
- The chemistry and pharmacology of privileged pyrroloquinazolines.Chao B, Li BX, Xiao X.Chao B, et al.Medchemcomm. 2015 Apr 1;6(4):510-520. doi: 10.1039/C4MD00485J.Medchemcomm. 2015.PMID:25937878Free PMC article.
- Subtype selectivity of α+β- site ligands of GABAA receptors: identification of the first highly specific positive modulators at α6β2/3γ2 receptors.Varagic Z, Ramerstorfer J, Huang S, Rallapalli S, Sarto-Jackson I, Cook J, Sieghart W, Ernst M.Varagic Z, et al.Br J Pharmacol. 2013 May;169(2):384-99. doi: 10.1111/bph.12153.Br J Pharmacol. 2013.PMID:23472935Free PMC article.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources